BusinessFEI and NovAliX Partner to Provide Electron Microscopy-based Structural Biology Services for the Pharmaceutical IndustryBy Nasdaq OMXMar 21, 2016, 12:00 PM UTC
BusinessHemispherx Biopharma Reviews Ampligen® Data With National Institute of Neurological Disorders and Stroke (NINDS)By Nasdaq OMXMar 10, 2016, 1:30 PM UTC
BusinessAchillion to Present at Two Upcoming Investor ConferencesBy Nasdaq OMXMar 3, 2016, 11:05 AM UTC
BusinessAgile Therapeutics Appoints Ajit S. Shetty, Ph.D., to Its Board of DirectorsBy Nasdaq OMXFeb 24, 2016, 9:15 PM UTC
BusinessAlimera Sciences to Report Fourth Quarter 2015 Financial Results on March 2, 2016By Nasdaq OMXFeb 18, 2016, 12:30 PM UTC
BusinessAchillion Initiates Phase 1 Study of ACH-4471, First Orally-Administered Small Molecule Complement Factor D InhibitorBy Nasdaq OMXFeb 11, 2016, 11:05 AM UTC
BusinessHemispherx Biopharma Exploring Possible Research Programs in Zika Virus Modeled on a Prior Alferon® N Clinical Trial on Closely Related Flavivirus (West Nile)By Nasdaq OMXFeb 9, 2016, 1:30 PM UTC
BusinessHemispherx Biopharma Introduces a Voluntary Stock Purchase Plan to Create Shareholder ValueBy Nasdaq OMXFeb 3, 2016, 1:30 PM UTC
